Mavorixafor Dosage

Medically reviewed by Drugs.com. Last updated on Jul 2, 2024.

Usual Adult Dose for WHIM Syndrome

Weight over 50 kg: 400 mg orally daily
Weight less than or equal to 50 kg: 300 mg orally daily

Comments:

• Dose should be taken on an empty stomach after an overnight fast, and at least 30 minutes before food.

Use: WHIM Syndrome (warts, hypogammaglobulinemia, infections and myelokathexis)

Usual Pediatric Dose for WHIM Syndrome

Weight over 50 kg: 400 mg orally daily
Weight less than or equal to 50 kg: 300 mg orally daily

Comments:

• Dose should be taken on an empty stomach after an overnight fast, and at least 30 minutes before food.

Use: WHIM Syndrome (warts, hypogammaglobulinemia, infections and myelokathexis) in patients 12 years of age and older

Renal Dose Adjustments

• Mild and Moderate Renal Dysfunction: No adjustment recommended.
• Severe Renal Dysfunction and End Stage Renal Disease: Not recommended.

Liver Dose Adjustments

• Mild Liver Dysfunction: No adjustment recommended.
• Moderate and Severe Liver Dysfunction: Not recommended.

Dose Adjustments

Use with Strong CYP450 3A4 Inhibitors:

• Reduce daily dosage to 200 mg when used concomitantly.

Precautions

CONTRAINDICATIONS:

• Use with drugs highly dependent on CYP450 2D6 for clearance

Safety and efficacy have not been established in patients younger than 12 years.

To report suspected adverse reactions, contact X4 Pharmaceuticals Inc., or the FDA at www.fda.gov/medwatch

Consult WARNINGS section for additional precautions.

Dialysis

Data not available.

Other Comments

Administration advice:

• Take once daily on an empty stomach after an overnight fast, and at least 30 minutes before food.
• Swallow the capsule whole. Do not open, break or chew.
• If a dose is missed, the next dose should be taken as scheduled. Do not take more than one dose each day.

Storage requirements:

• Refrigerate at 2C to 8C (36F to 46F)
• Keep the bottle tightly closed.
• Store in the original container to protect from moisture.

General:

• Advise patients to avoid eating or drinking products with grapefruit.

Monitoring:

• Obtain an EKG to assess QTc at baseline and monitor during treatment as clinically indicated in patients with risk factors.

Patient advice:

• Read the Patient Information and Instructions for Use.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer